Article
Down syndrome preleukemia and leukemia.
Pediatric clinics of North America - 1 Feb 2015
Maloney Kelly W, Taub Jeffrey W, Ravindranath Yaddanapudi, Roberts Irene, Vyas Paresh
Abstract excerpt
Children with Down syndrome (DS) and acute leukemias acute have unique biological, cytogenetic, and intrinsic factors that affect their treatment and outcome. Myeloid leukemia of Down syndrome (ML-DS) is associated with high event-free survival (EFS) rates and frequently preceded by a preleukemia condition, the transient abnormal hematopoiesis (TAM) present at birth. For acute lymphoblastic leukemia (ALL), their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
